DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,485,596 | +6.8% | 150,217 | 0.0% | 1.06% | +5.1% |
| Q2 2023 | $36,052,080 | +34.4% | 150,217 | +64.2% | 1.01% | +327.1% |
| Q1 2022 | $26,832,000 | -14.2% | 91,474 | -3.7% | 0.24% | -9.2% |
| Q4 2021 | $31,260,000 | +5.7% | 95,014 | -2.2% | 0.26% | -6.8% |
| Q3 2021 | $29,564,000 | +10.8% | 97,110 | -2.3% | 0.28% | +11.2% |
| Q2 2021 | $26,687,000 | +6.0% | 99,447 | -11.1% | 0.25% | +37.2% |
| Q1 2021 | $25,165,000 | -7.6% | 111,806 | -8.8% | 0.18% | -2.7% |
| Q4 2020 | $27,225,000 | +10.4% | 122,555 | +7.0% | 0.19% | +12.6% |
| Q3 2020 | $24,666,000 | +30.7% | 114,549 | +7.3% | 0.17% | +11.3% |
| Q2 2020 | $18,870,000 | +31.4% | 106,716 | +2.9% | 0.15% | +12.8% |
| Q1 2020 | $14,361,000 | -13.2% | 103,752 | -3.7% | 0.13% | +16.7% |
| Q4 2019 | $16,544,000 | -46.5% | 107,794 | -49.6% | 0.11% | -39.4% |
| Q3 2019 | $30,916,000 | +79.3% | 214,060 | +77.4% | 0.19% | +59.3% |
| Q2 2019 | $17,244,000 | -7.7% | 120,655 | -14.7% | 0.12% | -12.6% |
| Q1 2019 | $18,675,000 | +35.6% | 141,455 | +5.9% | 0.14% | +20.5% |
| Q4 2018 | $13,772,000 | +12.8% | 133,556 | +18.9% | 0.11% | +20.4% |
| Q3 2018 | $12,207,000 | +6.4% | 112,338 | -3.3% | 0.09% | +17.7% |
| Q2 2018 | $11,468,000 | -3.5% | 116,217 | -4.3% | 0.08% | +6.8% |
| Q1 2018 | $11,887,000 | – | 121,406 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |